Idera Pharmaceuticals reported $38.3M in Current Assets for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Aceto ACET:US 199.02M 17.28M
Alnylam Pharmaceuticals ALNY:US $ 2675.36M 49.8M
Amgen AMGN:US $ 24380M 5281M
Biogen BIIB:US $ 7162.3M 21.4M
Biomarin Pharmaceutical BMRN:US $ 2311.57M 46.27M
Cytrx CYTR:US 16.55M 7.79M
Dynavax Technologies DVAX:US $ 852.67M 268.76M
Eli Lilly And LLY:US $ 17808.3M 512.8M
Gilead Sciences GILD:US $ 14200M 275M
GlaxoSmithKline GSK:LN 18.25B 688M
Idera Pharmaceuticals IDRA:US $ 38.3M 5.18M
Mirati Therapeutics MRTX:US $ 1171.89M 106.2M
Nektar Therapeutics NKTR:US $ 986.14M 70.01M
Sarepta Therapeutics SRPT:US $ 2185.31M 79.91M
Seattle Genetics SGEN:US $ 3114.61M 16.1M
Ultragenyx Pharmaceutical RARE:US $ 846.88M 102.61M